The stock of Sensus Healthcare Inc (NASDAQ: SRTS) has increased by 6.87 when compared to last closing price of 8.36.Despite this, the company has seen a gain of 29.94% in its stock price over the last five trading days. zacks.com reported 2024-11-18 that The mean of analysts’ price targets for Sensus Healthcare (SRTS) points to a 39.7% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Is It Worth Investing in Sensus Healthcare Inc (NASDAQ: SRTS) Right Now?
The price-to-earnings ratio for Sensus Healthcare Inc (NASDAQ: SRTS) is above average at 15.65x. The 36-month beta value for SRTS is also noteworthy at 1.14. There are mixed opinions on the stock, with 2 analysts rating it as a “buy,” 3 rating it as “overweight,” 0 rating it as “hold,” and 0 rating it as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for SRTS is 13.27M, and at present, short sellers hold a 4.04% of that float. The average trading volume of SRTS on November 21, 2024 was 154.15K shares.
SRTS’s Market Performance
SRTS’s stock has seen a 29.94% increase for the week, with a 33.43% rise in the past month and a 31.86% gain in the past quarter. The volatility ratio for the week is 10.74%, and the volatility levels for the past 30 days are at 6.57% for Sensus Healthcare Inc The simple moving average for the past 20 days is 26.91% for SRTS’s stock, with a 66.31% simple moving average for the past 200 days.
Analysts’ Opinion of SRTS
Many brokerage firms have already submitted their reports for SRTS stocks, with Maxim Group repeating the rating for SRTS by listing it as a “Buy.” The predicted price for SRTS in the upcoming period, according to Maxim Group is $14 based on the research report published on November 15, 2024 of the current year 2024.
SRTS Trading at 36.90% from the 50-Day Moving Average
After a stumble in the market that brought SRTS to its low price for the period of the last 52 weeks, the company was able to rebound, for now settling with 2.88% of gains for the given period.
Volatility was left at 6.57%, however, over the last 30 days, the volatility rate increased by 10.74%, as shares surge +41.01% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +52.04% upper at present.
During the last 5 trading sessions, SRTS rose by +29.94%, which changed the moving average for the period of 200-days by +156.16% in comparison to the 20-day moving average, which settled at $7.04. In addition, Sensus Healthcare Inc saw 278.81% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at SRTS starting from Heinrich John, who sale 15,227 shares at the price of $6.24 back on May 20 ’24. After this action, Heinrich John now owns 59,940 shares of Sensus Healthcare Inc, valued at $95,016 using the latest closing price.
Heinrich John, the Director of Sensus Healthcare Inc, sale 4,773 shares at $5.95 during a trade that took place back on May 17 ’24, which means that Heinrich John is holding 75,167 shares at $28,399 based on the most recent closing price.
Stock Fundamentals for SRTS
Current profitability levels for the company are sitting at:
- 0.29 for the present operating margin
- 0.61 for the gross margin
The net margin for Sensus Healthcare Inc stands at 0.23. The total capital return value is set at 0.22. Equity return is now at value 18.86, with 16.87 for asset returns.
Based on Sensus Healthcare Inc (SRTS), the company’s capital structure generated 0.01 points at debt to capital in total, while cash flow to debt ratio is standing at 4.09. The debt to equity ratio resting at 0.01. The interest coverage ratio of the stock is 49.14.
Currently, EBITDA for the company is 30000.0 with net debt to EBITDA at -1.77. When we switch over and look at the enterprise to sales, we see a ratio of 3.02. The receivables turnover for the company is 2.44for trailing twelve months and the total asset turnover is 0.69. The liquidity ratio also appears to be rather interesting for investors as it stands at 10.52.
Conclusion
In summary, Sensus Healthcare Inc (SRTS) has had a better performance as of late. Analysts have bullish opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
